FDA Import Refusal 112-2192253-9/1/16 — GlaxoSmithKline LLC
The FDA refused shipment 112-2192253-9/1/16 from GlaxoSmithKline LLC (United States) on July 16, 2006. The refused product falls under Drugs and Biologics — LAMOTRIGINE (ANTI-CONVULSANT). Cited charge: 179 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- July 16, 2006
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61MCA38 LAMOTRIGINE (ANTI-CONVULSANT)
- Charges
- 179